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Abstract
Background: ATP1A3-related disorders include rapid-onset dystonia–parkinsonism (RDP or DYT12), alternating hemiplegia of childhood (AHC), and CAPOS
syndrome (Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy, and Sensorineural hearing loss).
Case Report: We report two cases with intermediate forms between RDP and AHC. Patient 1 initially presented with the AHC phenotype, but the RDP
phenotype emerged at age 14 years. The second patient presented with levodopa-responsive paroxysmal oculogyria, a finding never before reported in ATP1A3-
related disorders. Genetic testing confirmed heterozygous changes in the ATP1A3 gene in both patients, one of them novel.
Discussion: Intermediate phenotypes of RDP and AHC support the concept that these two disorders are part of a spectrum. We add our cases to the phenotype–
genotype correlations of ATP1A3-related disorders.
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Introduction
Historically, heterozygous ATP1A3 mutations were initially
described in rapid-onset dystonia–parkinsonism (RDP or DYT12)
(MIM 128235).1 Advances in genetic techniques led to the subsequent
discovery that abnormalities in the same gene were responsible for
some forms of alternating hemiplegia of childhood (AHC) (MIM
614820),2 and also the CAPOS syndrome (Cerebellar ataxia,
Areflexia, Pes cavus, Optic atrophy and Sensorineural hearing loss)
(MIM 601338).3 Although clinical features of RDP and AHC differ, on
rare occasions patients have been reported with clinical features
overlapping between the two,4,5 suggesting that RDP and AHC are
disorders in the same spectrum4,6,7 rather than just allelic disorders as
initially envisioned.8
In this paper, we present two unusual patients with ATP1A3-related
disorders with clinical features overlapping between RDP and AHC.
Our first patient carried a novel missense variant previously unknown
in intermediate phenotypes or any ATP1A3-related disorders. Our
second patient carried a known deleterious mutation and possessed an
unusual phenotype never before reported in the intermediate form.
These two unique patients illustrate the expanding phenotypic
spectrum of ATP1A3-related disorders.
Written informed consent was obtained from the patients for
publication of this case report and any accompanying images.
Case report
Patient 1
A 24-year-old female without family history of neurologic illness
presented for evaluation of global developmental delay from early
childhood and monthly alternating hemiplegic episodes lasting minutes
to hours since her early teens. She usually recovered from these
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episodes after sleeping, but at age 14 she developed a severe episode
that was not terminated by sleep. A diagnosis of “AHC” was made at
this time, and a hospital evaluation for epilepsy was negative. Since
that event, she developed continuous and unremitting posturing and
functional impairment of the left arm, dysarthria, and lower cranial
dystonia with marked drooling.
On examination a prominent risus sardonicus, marked dysarthria,
and prominent drooling were evident (Video 1). Ocular motor
examination was normal, and asymmetric dystonic posturing of the
arms was present accompanied by parkinsonism. A rostrocaudal
gradient of her dystonia was noted with only very mild involvement in
her legs. Deep tendon reflexes were 3+ throughout.
Sanger sequencing of exons 1–23 in the ATP1A3 gene at a
commercial laboratory revealed a novel heterozygous missense variant
(NM_152296.4: c.2851G.A; NP_689509.1: p.E951K) in exon 21.
This variant is not found in large publically available cohorts.9–11
In silico, this variant is predicted to be damaging by SIFT (Sorting
Intolerant From Tolerant) and probably damaging by PolyPhen-2
(with a score of 0.998).12,13 The position is highly conserved across
multiple vertebrate species (from humans to zebrafish; Genomic Evo-
lutionary Rate Profiling [GERP] score 2.91).14 Though not reported,
this variant was also seen once in another patient with AHC in a
research cohort in Utah (T. Newcomb, personal communication, June
12, 2015). Based on the new American College of Medical Genetics and
Genomics standards and guidelines for interpretation of sequence
variants, this variant is classified as likely to be pathogenic.15 Her parents
elected not to pursue testing since they were asymptomatic. Botulinum
toxin injection to the left arm provided temporary relief of dystonia.
Patient 2
A 10-year-old female presented to our office with her parents after
being adopted from China 8 months prior. Information on her early
development was limited. At age 1 year she was brought to an
orphanage with obvious global developmental delay. When her
adoptive mother met her in China, she was malnourished, immobile,
mute, drooling, and unable to use her arms to feed herself but she
could sit and walk. She seemed alert however, and after a few visits
recognized her adoptive mother. She had experienced frequent epi-
sodes since childhood that had been labeled epileptiform (Video 2).
Review of the video showed clear oculogyria with upward and lateral
deviation of both eyes, accompanied by neck posturing. After her first
evaluation in the United States, her referring neurologist started her on
levodopa 200 mg/day, and the episodes dramatically improved, along
with improved motor performance.
Examination in the office revealed a cooperative young girl with
mildly soft and indistinct speech. Ocular motor examination was
normal. There was symmetric mild dystonic posturing of both hands,
with slow choreiform movements of her fingers, mild incoordination of
the hands and no overt parkinsonism. She walked well with good arm
swing. Deep tendon reflexes were 1+ throughout.
Owing to the dramatic response to levodopa and presence of
oculogyria, our differential diagnosis included levodopa-responsive
forms of aromatic L-amino acid decarboxylase (AADC)16 and tyrosine
hydroxylase (TH) deficiency. Surprisingly, whole exome sequencing
(and confirmed using the Sanger method) at a commercial laboratory
revealed a known pathogenic heterozygous mutation (NM_152296.4:
c.2401G.A; NP_689509.1: p.D801N) in exon 17 of the ATP1A3
gene.17–19 There were no mutations found in the DDC or GCH1 genes.
Coverage for these two loci was at 100% and at least 106 (N.
Alexander, personal communication, August 8, 2015). Since the TH
gene was not well covered by whole exome sequencing, separate TH
Video 1. The first patient’s office examination demonstrates a
prominent risor grin, drooling and marked dysarthria. Asymmetric
dystonia of the left arm and hand led to flexion posturing of the elbow,
prominent wrist and finger flexion, and ulnar deviation of her wrist. A
rostrocaudal gradient of dystonia is evident, with preservation of walking.
Video 2. Patient number 2 is shown in three segments. segment 1.
A home video demonstrates an oculogyric episode, with eyes elevated upward
with intermittent lateral deviation, accompanied by head tilt to the left and jaw
deviation to the right. She was uncomfortable but did not lose consciousness.
This episode lasted almost 1 minute, after which she partially recovered and
looked exhausted. About 20 seconds afterwards, she developed oculogyria with
upward eye deviation again. Segment 2. The second home video segment
shows her in a stroller. She developed dystonic posturing of her neck with tilting
to the left and lateral rotation to the right, accompanied by dystonic posturing of
her hands and jaw opening. She recovered before her mother transferred her to
a cushion. Segment 3. This video segment shows her during her initial office
evaluation, already treated with levodopa. Her speech was mildly soft and
indistinct with no ocular motor abnormalities. Mild symmetric dystonic
posturing of both hands with intermittent choreiform movements of her
fingers was present. There was no parkinsonism or dysmetria. She walked well
with good arm swing.
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gene sequencing was performed at the same commercial laboratory
using the Sanger method, which included all exons, flanking splice
regions, and the cyclic adenosine monophosphate (cAMP) response
element spanning c-74 to c-67 in the promoter region. TH deletion/
duplication analysis was also performed via a dense exonic
comparative genomic array. These methods did not detect any
mutations, deletions, or duplications in the TH gene. Test method
details for whole exome sequencing, TH sequencing, and deletion/
duplication analysis can be found at the commercial laboratory’s
website (www.genedx.com). Cerebrospinal fluid studies were not
available.
Discussion
We present two unusual patients with missense changes in the
ATP1A3 gene whose clinical features overlapped between AHC and
RDP. In classic AHC, patients experience symptom onset before
18 months of age, consisting of paroxysmal alternating hemiplegia
events, developmental delay, and drooling. The classic RDP pheno-
type is often milder than AHC, with the main feature of rapid-onset
parkinsonism over minutes to weeks, and stabilization of symptoms
with minimal progression after a month. A rostrocaudal gradient of
symptoms, asymmetric involvement, and prominent bulbar involve-
ment including dysarthria and/or dysphagia is characteristic.
Our two patients’ clinical histories and examination overlapped
between these two disorders (Table 1). In fact, Patient 1 started with an
AHC phenotype, and her RDP phenotype emerged at age 14 years.
Sasaki et al.5 reported and reviewed cases in the literature with
intermediate phenotype between AHC and RDP,4,20 all of which (six
patients) had D923N mutations in the ATP1A3 gene. Rosewich et al.6
later reported two patients with intermediate phenotype and the novel
mutations I810F and W382R. The missense variant in our first
patient, E951K, has never been reported in ATP1A3-related disorders,
including the intermediate phenotype between AHC and RDP. The
mutation in Patient 2, D801N, is one of the most common mutations
reported with the classic AHC phenotype,21 but has never been
reported in the intermediate form of AHC and RDP. Although almost
all reported genetic derangements in ATP1A3-related disorders are de
novo,22 parental genetic testing was not available in either of our
patients. Phenotype–genotype correlations in ATP1A3-related disor-
ders are summarized in Table 2.
The ATP1A3 gene encodes the a3-subunit of the enzyme Na+/K+
ATPase. This enzyme functions to pump three molecules of Na+ out
and two molecules of K+ into the cell to maintain the electrochemical
gradient at the plasma membrane prior to depolarization. Both the
E951K and D801N variants are located in the transmembrane regions
of the ATP1A3 protein, which is also a cation-transporting ATPase
region near the C-terminus. In previous studies, it was found that
mutations causing AHC phenotypes tend to affect the transmembrane
regions or functional domains compared to those causing RDP
phenotypes,6 although this association cannot be applied in all cases.
Interestingly, Patient 2 presented with paroxysmal oculogyria
dramatically responsive to levodopa, a phenomenon never reported
before in AHC or RDP. AHC patients can have episodic ocular motor
abnormalities, reported in up to 93% in one study,23 including
nystagmus and intermittent esotropia or exotropia. In 1993, Dobyns et
al.24 reported two out of 12 RDP patients with persistent (not
paroxysmal) oculogyric crisis at the onset, lasting days or weeks.
Genetic testing of the ATP1A3 gene was not available at that time, but
subsequently one of them was found to have the I758S mutation in the
ATP1A3 gene.25 Since then, oculogyria has not been reported in RDP.
To our knowledge, this is the first patient reported with paroxysmal
oculogyria associated with an ATP1A3 mutation. This atypical feature
initially pointed us to other differential diagnoses of levodopa-responsive
oculogyria in children, especially disorders in the monoamine synthetic
Table 1. Clinical Features of Our Patients with Intermediate Forms of Alternating Hemiplegia of Childhood and Rapid-
onset Dystonia–Parkinsonism
Clinical Feature Patient 1 Patient 2
Developmental delay + +
Drooling +1 +
Paroxysmal alternating hemiplegia +
Paroxysmal oculogyria +1
Hypotonia +
Recovery of the episode with sleep +
Asymmetric dystonia +1
Mild bilateral hand dystonia +1
Rostrocaudal gradient of dystonia +1
Speech involvement +1 +1 (mild)
Stabilization of the symptoms over time +
Clinical features of each patient were classified according to whether they were more compatible with alternating hemiplegia (in pink) vs. rapid-
onset dystonia–parkinsonism (in green). “+” sign indicates the presence of the features in each patient.
1Features that are seen in the videos.
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pathway such as AADC and TH deficiencies. Given the dramatic
improvement in our patient and in the other three patients in the same
family with a novel AADC mutation,16 a trial of levodopa in children
presenting with unexplained oculogyria seems warranted.
Our two cases expand our current knowledge of the phenotype–
genotype variations and natural history of ATP1A3-related disorders,
and emphasize that AHC and RDP are part of the same spectrum.
Recognition of the overlapping phenotypes will help guide clinicians
toward a correct molecular diagnosis for their patients.
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